by admin | Feb 16, 2021 | Publications
Risk of morbidity and mortality in patients with type 2 diabetes treated with sodium-glucose cotransporter-2 inhibitor and/or dipeptidyl peptidase-4 inhibitor: a nationwide study Gábor Sütő, Gergő A Molnár, Gyorgy Rokszin, Ibolya Fábián, Zoltan Kiss, Zoltán Szekanecz,...
by admin | Jan 18, 2021 | Publications
Improvement in age- and sex-dependent mortality in patients with atrial fibrillation between 2011 and 2016 – a nationwide retrospective study from Hungary Zoltán Kiss, László Márk, Béla Herczeg, Dániel Aradi, György Rokszin, Ibolya Fábián, Krisztián Horváth, István...
by admin | Apr 25, 2020 | Publications
Lung Cancer in HungaryKrisztina Bogos, Zoltán Kiss, Gabriella Gálffy, Lilla Tamási, Gyula Ostoros, Veronika Müller, László Urbán, Nóra Bittner, Veronika Sárosi, Aladár Vastag, Zoltán Polányi, Zsófia Nagy-Erdei, Zoltán Vokó, Balázs Nagy, Krisztián Horváth, György...
by admin | Apr 18, 2020 | Publications
Changes in mortality rates and ratios in people with pharmacologically treated type 2 diabetes mellitus between 2001 and 2016 in HungaryGyörgy Jermendy, Zoltán Kiss, György Rokszin, Ibolya Fábián, István Wittmann, Péter Kempler AimType 2 diabetes mellitus (T2DM) is...
by RxTarget.hu | Apr 16, 2020 | Publications
Survival Benefits of Second-line Axitinib Versus Everolimus After First Line Sunitinib Treatment in Metastatic Renal Cell Carcinoma Lajos Géczi, György Bodoky, György Rokszin, Ibolya Fábián, László Torday (Pathology & Oncology Research,...
by RxTarget.hu | Jan 2, 2020 | Publications
Changes in the incidence and prevalence of type 1 and type 2 diabetes among 2 million children and adolescents in Hungary between 2001 and 2016 – a nationwide population-based study (Arch Med Sci 2020; 16 (1): 34–41) László Barkai, Zoltán Kiss, György Rokszin, Zsolt...
